$WKSP
Worksport Ltd Stock $wksp

$wksp Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224020125 Filed on May 16, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$1.922M	$512.6K	$31.93K
YoY Change	861.49%	1505.75%	-33.18%
Cost Of Revenue	$1.625M	$475.2K	$19.76K
YoY Change	960.04%	2305.13%	-47.98%
Gross Profit	$296.6K	$37.46K	$12.17K
YoY Change	537.05%	207.82%	24.16%
Gross Profit Margin	15.44%	7.31%	38.11%
Selling, General & Admin	$3.425M	$2.741M	$2.674M
YoY Change	49.34%	2.51%	-4.8%
% of Gross Profit	1154.7%	7318.17%	21975.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$232.8K	$383.2K	$195.0K
YoY Change	-12.55%	96.52%	75.59%
% of Gross Profit	78.49%	1022.93%	1602.32%
Operating Expenses	$4.207M	$3.677M	$3.542M
YoY Change	11.15%	3.81%	26.1%
Operating Profit	-$3.911M	-$3.639M	-$3.530M
YoY Change	4.6%	3.1%	26.11%
Interest Expense	-$149.8K	$123.6K	$165.1K
YoY Change	-179.73%	-25.14%	-992.91%
% of Operating Profit
Other Income/Expense, Net	-$102.7K	-$75.19K	$6.678K
YoY Change	74.77%	-1225.95%	-133.68%
Pretax Income	-$4.013M	-$3.715M	-$3.523M
YoY Change	5.69%	5.43%	25.04%
Income Tax
% Of Pretax Income
Net Earnings	-$4.013M	-$3.715M	-$3.523M
YoY Change	5.69%	5.43%	25.04%
Net Earnings / Revenue	-208.86%	-724.62%	-11036.08%
Basic Earnings Per Share	-$0.15	-$0.18	-$0.21
Diluted Earnings Per Share	-$0.15	-$0.18	-$0.21
COMMON SHARES
Basic Shares Outstanding	25.59M shares	24.10M shares	17.16M shares
Diluted Shares Outstanding	25.96M shares	21.19M shares	17.16M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.426M	$3.537M	$10.49M
YoY Change	-41.95%	-66.28%	-59.36%
Cash & Equivalents	$3.426M	$3.537M	$10.49M
Short-Term Investments
Other Short-Term Assets	$151.8K	$342.2K	$2.239M
YoY Change	-85.47%	-84.72%	-45.54%
Inventory	$6.387M	$6.540M	$1.604M
Prepaid Expenses
Receivables	$623.4K	$156.3K	$100.6K
Other Receivables	$140.9K	$155.3K	$272.6K
Total Short-Term Assets	$10.74M	$10.74M	$14.71M
YoY Change	2.76%	-26.93%	-52.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.31M	$14.31M	$12.79M
YoY Change	1.93%	11.89%	442.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$90.73K	$90.73K	$90.73K
YoY Change	0.0%	0.0%	271.54%
Other Assets
YoY Change
Total Long-Term Assets	$16.44M	$16.55M	$15.39M
YoY Change	-0.57%	7.5%	394.04%
TOTAL ASSETS
Total Short-Term Assets	$10.74M	$10.74M	$14.71M
Total Long-Term Assets	$16.44M	$16.55M	$15.39M
Total Assets	$27.19M	$27.29M	$30.10M
YoY Change	0.72%	-9.32%	-11.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.750M	$2.262M	$2.022M
YoY Change	45.9%	11.89%	60.69%
Accrued Expenses	$503.8K	$281.7K	$409.1K
YoY Change	26.32%	-31.15%	93.36%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$5.300M	$2.190K
YoY Change	-100.0%	241909.13%	-96.47%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.254M	$7.844M	$2.433M
YoY Change	-67.34%	222.41%	35.54%
LONG-TERM LIABILITIES
Long-Term Debt	$5.300M	$0.00	$5.300M
YoY Change		-100.0%
Other Long-Term Liabilities	$485.5K	$546.6K	$780.3K
YoY Change	-29.98%	-29.95%	195.29%
Total Long-Term Liabilities	$5.785M	$546.6K	$6.080M
YoY Change	734.49%	-91.01%	2200.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.254M	$7.844M	$2.433M
Total Long-Term Liabilities	$5.785M	$546.6K	$6.080M
Total Liabilities	$8.039M	$8.390M	$8.513M
YoY Change	5.87%	-1.44%	313.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$56.04M	-$52.03M	-$36.91M
YoY Change	37.68%	40.97%
Common Stock	$2.852K	$2.410K	$1.716K
YoY Change	63.72%	40.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.15M	$18.90M	$21.58M
YoY Change
Total Liabilities & Shareholders Equity	$27.19M	$27.29M	$30.10M
YoY Change	0.72%	-9.32%	-11.38%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$4.013M	-$3.715M	-$3.523M
YoY Change	5.69%	5.43%	25.04%
Depreciation, Depletion And Amortization	$232.8K	$383.2K	$195.0K
YoY Change	-12.55%	96.52%	75.59%
Cash From Operating Activities	-$3.627M	-$2.795M	-$2.934M
YoY Change	17.59%	-4.76%	45.52%
INVESTING ACTIVITIES
Capital Expenditures	$122.8K	$213.0K	$1.087M
YoY Change	-91.87%	-80.41%	-277.01%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$66.31K
YoY Change		-100.0%
Cash From Investing Activities	-$122.8K	-$213.0K	-$1.153M
YoY Change	-91.87%	-81.53%	87.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.639M	$3.179M	-$43.90K
YoY Change	50932.4%	-7340.29%	-65.67%
NET CHANGE
Cash From Operating Activities	-3.627M	-$2.795M	-$2.934M
Cash From Investing Activities	-122.8K	-$213.0K	-$1.153M
Cash From Financing Activities	3.639M	$3.179M	-$43.90K
Net Change In Cash	-110.9K	$171.2K	-$4.132M
YoY Change	-97.58%	-104.14%	49.78%
FREE CASH FLOW
Cash From Operating Activities	-$3.627M	-$2.795M	-$2.934M
Capital Expenditures	$122.8K	$213.0K	$1.087M
Free Cash Flow	-$3.750M	-$3.008M	-$4.021M
YoY Change	-18.38%	-25.21%	186.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001096275
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2024Q1	WKSP	Purchase Of Software PurchaseOfSoftware		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40681
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	Worksport Ltd
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-2696895
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2500 N America Dr
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	West Seneca
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14224
CY2024Q1	dei	City Area Code CityAreaCode	(888)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	554-8789
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25594972	shares
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	5300000	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	5300000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	8390124	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7775373	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	299000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	299000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24100201	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24100201	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20320503	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20320503	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	2410	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2032	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	69018715	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	64685693	usd
CY2024Q1	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	1577	usd
CY2023Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	1577	usd
CY2024Q1	WKSP	Share Subscriptions Payable ShareSubscriptionsPayable	1917585	usd
CY2023Q4	WKSP	Share Subscriptions Payable ShareSubscriptionsPayable	1814152	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52027834	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48313177	usd
CY2024Q1	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax	-8580	usd
CY2023Q4	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax	-8580	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	18900719	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18178543	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27290843	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25953916	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	512637	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31925	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	475181	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19757	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	37456	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	12168	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2674318	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2129612	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	66777	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	544351	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	943778	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	868611	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	7951	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	458	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3676922	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3542116	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3639466	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3529948	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	123598	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	165099	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	3054	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	119828	usd
CY2024Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	45353	usd
CY2023Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	44456	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	7493	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-75191	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6678	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3714657	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3523270	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21188070	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21188070	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17159376	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17159376	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	24118254	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	988117	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3523270	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	21583101	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18178543	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18178543	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1241563	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3195201	usd
CY2024Q1	WKSP	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	69	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3714657	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	18900719	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	18900719	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	3714657	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	3523270	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1241563	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1453617	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	383147	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	194974	usd
CY2024Q1	WKSP	Change In Operating Lease ChangeInOperatingLease	-1988	usd
CY2023Q1	WKSP	Change In Operating Lease ChangeInOperatingLease	20493	usd
CY2024Q1	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-2087959	usd
CY2023Q1	us-gaap	Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-1895172	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	706645	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	1039238	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2794604	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2934410	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	66308	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	212969	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1086921	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-212969	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1153229	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Long Term Debt And Capital Securities ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities	-16495	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Long Term Debt And Capital Securities ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities	-43904	usd
CY2024Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	69	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3195201	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3178775	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-43904	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	171202	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4131543	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3365778	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14620757	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3536980	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10489214	usd
CY2023Q1	WKSP	Purchase Of Software PurchaseOfSoftware	72467	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	144020	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	159156	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3536980	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52027834	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3714657	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3523270	usd
CY2024Q1	WKSP	Working Capital WorkingCapital	2901401	usd
CY2023Q4	WKSP	Working Capital WorkingCapital	1956894	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52027834	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48313177	usd
CY2024Q1	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	32500000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	30000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-10538	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	4523	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2908354	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	257423	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	5215	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1155090	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	742590	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5984977	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1717669	usd
CY2024Q1	us-gaap	Other Inventory OtherInventory	101660	usd
CY2023Q4	us-gaap	Other Inventory OtherInventory	101660	usd
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	453209	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1812163	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	6539846	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	3631492	usd
CY2024Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	59009	usd
CY2023Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	5215	usd
CY2024Q1	WKSP	Prepaid Deposit PrepaidDeposit	283150	usd
CY2023Q4	WKSP	Prepaid Deposit PrepaidDeposit	1492034	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	342159	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1497249	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	59009	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2047100	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1664580	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14313885	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14483436	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	299000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Reclassifications Reclassifications	<p id="xdx_80D_eus-gaap--Reclassifications_zf7QbFULds97" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_82B_z4MEnmSOMco6">Changes in Cash Flows from Operating Assets and Liabilities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--ScheduleOfChangesInOperatingAssetsAndLiabilitiesTableTextBlock_z578QWOA0hvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The changes to the Company’s operating assets and liabilities for the three months ended March 31, 2024 and 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zINcx4l7Xu06" style="display: none">Schedule of Changes in Operating Assets and Liabilities</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20240101__20240331_zs8ZTkZzhYH4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230101__20230331_z7wwD7h1hTAg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--IncreaseDecreaseInAccountsReceivable_iN_di_maIDIOCzg9T_zmTN5M6vmEw5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Decrease (increase) in accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">306,778</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(38,013</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInOtherReceivables_iN_di_maIDIOCzg9T_zkFJlyUg4KT2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Decrease (increase) in other receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,538</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,523</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--IncreaseDecreaseInInventories_iN_di_maIDIOCzg9T_z5QOj9IQvrha" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Decrease (increase) in inventory</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,908,354</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(257,423</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_iN_di_maIDIOCzg9T_zp9ikT4BNaN4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Decrease (increase) in prepaid expenses and deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,155,090</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(742,590</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInAccruedTaxesPayable_msIDIOCzg9T_zhRQX5WRdBga" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Increase (decrease) in taxes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(81,385</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,110</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_msIDIOCzg9T_zk1bouneFy45" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Increase (decrease) in accounts payable and accrued liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">810,688</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,799</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--IncreaseDecreaseInOperatingCapital_iNT_di_mtIDIOCzg9T_zTYXDNevX5h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in operating assets and liabilities</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(706,645</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,039,238</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A6_zxOYgeQ66um7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-306778	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38013	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	126034	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-81385	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	10110	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	810688	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6799	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	706645	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	1039238	usd
CY2019	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	10000000	shares
CY2019	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	50000	usd
CY2024Q1	WKSP	Advanced Receivable For Stock Issuance AdvancedReceivableForStockIssuance	24423	usd
CY2023Q4	WKSP	Advanced Receivable For Stock Issuance AdvancedReceivableForStockIssuance	24423	usd
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	66308	usd
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	90000	cad
CY2024Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	3054	usd
CY2024Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	4129	cad
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	66308	usd
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	90000	cad
CY2024Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	3167	usd
CY2024Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	4275	cad
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	803006	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	917354	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	278064	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	328229	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	546566	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	608761	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	133796	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	135784	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	122156	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	343496	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	278352	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	279815	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	46863	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	948526	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	123896	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	824630	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	278064	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	546566	usd
CY2020	us-gaap	Proceeds From Loans ProceedsFromLoans	28387	usd
CY2020	us-gaap	Proceeds From Loans ProceedsFromLoans	40000	cad
CY2020	WKSP	Debt Instrument Loan Forgiveness Percentage DebtInstrumentLoanForgivenessPercentage	0.25	pure
CY2022Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	28387	usd
CY2022Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	40000	cad
CY2023Q1	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	7493	usd
CY2023Q1	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	10000	cad
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21188070	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21188070	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17159376	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17159376	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8950242	shares
CY2023Q4	us-gaap	Share Price SharePrice	89
CY2024Q1	us-gaap	Share Price SharePrice	69
CY2023	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	400000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	20118080	shares
CY2024Q1	WKSP	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y11M19D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	11627924	shares
CY2023Q4	WKSP	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	2.78
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3939924	shares
CY2022Q4	WKSP	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	5.84
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	9178156	shares
CY2024Q1	WKSP	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	0.62
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	8575000	shares
CY2023	WKSP	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	1.09
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	688000	shares
CY2024Q1	WKSP	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercise Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExerciseWeightedAverageExercisePrice	0.0001
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	887000	shares
CY2023	WKSP	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercise Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExerciseWeightedAverageExercisePrice	0.0001
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	20118080	shares
CY2024Q1	WKSP	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	1.89
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	11627924	shares
CY2023Q4	WKSP	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	2.78
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5063856	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.96
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	785000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.74
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	68800	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.17
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4743356	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.80
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	464500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.02
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5132656	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.95
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5063856	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.96
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.57
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	5.50
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	5132656	shares
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P8Y4M20D
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	1.95
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1250625	shares
CY2024Q1	WKSP	Rental Income Operating RentalIncomeOperating	45353	usd
CY2023Q1	WKSP	Rental Income Operating RentalIncomeOperating	44456	usd

Files In Submission

Name	View Source	Status
0001493152-24-020125-index-headers.html	Edgar Link	pending
0001493152-24-020125-index.html	Edgar Link	pending
0001493152-24-020125.txt	Edgar Link	pending
0001493152-24-020125-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex32-3.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wksp-20240331.xsd	Edgar Link	pending
wksp-20240331_cal.xml	Edgar Link	unprocessable
wksp-20240331_def.xml	Edgar Link	unprocessable
wksp-20240331_lab.xml	Edgar Link	unprocessable
wksp-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WKSP
Worksport Ltd Stock $wksp

2024 Q2 Form 10-Q Financial Statement

#000149315224020125 Filed on May 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKSP Worksport Ltd Stock $wksp

2024 Q2 Form 10-Q Financial Statement

#000149315224020125 Filed on May 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKSP
Worksport Ltd Stock $wksp